Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What's the clue?
It's funny to see band wagon jumpers on here who don't have a clue about SINT.....
Meeting isn't until may 14th
Which if approved won't be actionable for up to 1yr but discretionary at their own will again if shareholders pass.
Pps is looking great. Giving reason not to pass.
This could easily see .25cent by then, if not way sooner.
I say play it by ear. Take a lil risk. Make great reward
How many new shares short for post RS? Theres going to be 1 or more offerings post RS. 400k to 1.2m is too few shares. Yes i still recommend having a few shares in case the first is a rights offering. Course rights offerings are usually around shareholders vote on board seats. Id expect a new shareholder plan vote this year since the last one got voted down.
Setting aside the games being played with the stock, Sintx is worth watching.
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Sonny should have waited 2 weeks. He could have raised twice as much for the same amount of shares. Anyway, regardless the games, some made mucho dinero today. We're talking 15-20 million exchanging hands. Quite a bit for literally a penny stock. Almost 500 million shares...wow!
Aerospace & Defense and Energy sectors now represent significant growth opportunities for us across our product portfolio. We also anticipate continued growth in our biomedical business, supported by new specialty opportunities and the recent introduction of a new silicon nitride spinal implant by our partner, CTL Amedica,” added Mr. O’Brien.
Looks like those hfunds are pumping and dumping for some more profit.
Dont you find it funny that China of all places banned Crypto? We can believe it was to protect its citizens from those scams as claimed.
"Virtual currency-related business activities are illegal financial activities," the People's Bank of China said, warning it "seriously endangers the safety of people's assets".
Its value is being lauded as a speculative asset, derived from increases generated solely from increased demand, and not as a stable asset. Buying it leads to higher prices, which raises hype, which leads to higher buying, and repeat. The hype cycle doesn't seem sustainable. Once investing starts to slow, the market value would stagnate compared to actual business ventures that generate actual income and value, so Bitcoin would inevitably be sold, starting the inverse of that cycle and therefore collapse.
I heard on a finance podcast that, for a lot of different digital currency brands, much of the coins are held by just a few key shareholders, risking the likelihood of a "pump and dump" because those key shareholders are betting on #1 happening and they want to sell their stock before the crash, with said selling actually causing it.
Bitcoin is the only thing in this world that is given an incredible amount of value, with absolutely nothing backing it except collective faith.
It may become a stable asset at some point, once adoption has reached massive, global, decentralized levels. But that is currently not the case. It’s still very vulnerable to value manipulation by large players who hold large amounts.
Cryptocurrency is a scam.
All of it, full stop — not just the latest pump-and-dump “shitcoin” schemes, in which fraudsters hype a little-known cryptocurrency before dumping it in unison, or “rug pulls,” in which a new cryptocurrency’s developers abandon the project and run off with investor funds. All cryptocurrency and the industry as a whole are built atop market manipulation without which they could not exist at scale.
This would, of course, kill off cryptocurrency almost entirely, relegating it back to an oddity of the tech enthusiast. No one should shed a tear. Cryptocurrencies have virtually no legal use case. They’re great for facilitating ransomware, laundering money, distributing narcotics and child porn, running Ponzi schemes, and… not much else. They fail as currencies due to high transaction costs. They fail as “digital gold” or a “store of value” because they consume ludicrous amounts of energy to run what is essentially a glorified spreadsheet.
China already banned cryptocurrencies entirely, and India and Pakistan are poised to do the same.
Michael Morell, who served as acting director of the agency on two separate occasions under President Obama, also sees the value of Bitcoin to the intelligence community.
Earlier this year, Morell called blockchain technology a "boon for surveillance" in a report, published by the Coinbase- and Square-led Crypto Council for Innovation. The report defended the cryptocurrency against claims that its best use case is for criminal enterprise. Instead, the public nature of transactions makes it an "underutilized forensic tool for governments to identify illicit activity."
it was arguably a referendum on “fake it till you make it” practices, such as intentionally overstating, and thereby misrepresenting, a fledgling company’s current capabilities, success, or profitability, while banking on the notion that its aspirations will eventually follow the desired trajectory and become a reality.
Awesome 👌 bounce...
Bought this morning...
GhosT
150M and counting. Wow!
Oh my....now crypto is a 'known' scam? Fortunately though, it is only suspected of being driven by military ops. Until it is confirmed (by you know who), we can go on with our daily lives. Tsla is compared to Theranos; one that has sold tons of vehicles still on the road vs one that had a product that didn't work. If that's not enough, the President apparently is ignorant or knowingly involved in the scam, as he's forcing everything (if the courts let him) electric, despite being told (at least on this forum) that magnetic rays are the apparent destruction of maybe everything? Must be me (as I know it could never be the poster I'm referring to) but this 'reasoning' appears to be getting more bizarre by the day!
Go Sint! The pumpers on ST are non stop. Maybe it's time for this 'legit' company to double, triple or even quadruple it's value to...almost a dime! Oh my, for the second time.....
Gamestop pump made people alot of money. Crypto too. Crypto, including Bitcoin, are known scams (i suspect military/intelligence community is behind crypto pumps to help fund blackops, etc..) and Gamestop was a giant pump n dump. Tesla is also a scam. Its a fake it until it makes it scam on a larger scale than Theranos which also made people money until it lost them alot. Tesla would never have reach the heights it did without the perpetual lies about how quickly it could bring a robotaxi network and a self driving Uber like network to market (it may never be able to achieve true full self driving). Those lies helped pump Teslas stock which also helped drive sales because alot of investors bought 1 or more Teslas.
The polar opposite is occurring here. Instead of Sintx being pumped to help fund the tech, its bashed/stock driven downward to distract from the importance of the tech, the techs sheer value, and possibly its ties to Zimmer Biomet. One only need look at posters comments about Masks to know this is true. Yes the commercialization deal with O2 fell through. However the IP was developed, the IP is free to commercialize with much larger partners, and that IP should have increased Sintx marketcap as it represents multiple commercializable products (imbuing Si3N4 into fabrics). Currently Sintx has 1 or more strategic partners in regards to this tech. Sintx IP has value, bashers treat the IP as if its worthless. So too does the market which i believe to be highly manipulated here.
We have several partnerships exploring opportunities in face masks, filters, wound care, and coatings.
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Definitely wish I had the Series B preferred. Their coversion price just resets with each RS. While a 300:1 RS will reduce the conversion count to like 4k shares, once the next offering hits that'll grow again.
I can only hope theres another rights offering allowing holders to exchange for more favorable conversions rate.
Rights offerings with full ratchet anti-dilution protections are the only protection from these RS and offerings.
Congrats Sint for putting out another filing, correcting the Special Meeting day and date. Took a while, but you finally got it figured out! Congrats again...
Start reeling $$$$$$ fish on $$$$$$
In 2007 Sintx tried to IPO for a valuation more akin to other material/implant companies in the ortho market; Implex (~225m) and Spinal Dynamics (275m) at $225m. This was before a single product was on the market. If you go through that IPO paperwork, Zimmer was very much present as several of Sintx personnel were connected to it or Centerpulse which it acquired. Fast forward to the 2013 IPO paperwork and Sintx tried to IPO for only 75m with Zimmer being removed/not disclosed from the IPO paperwork. To me theres a major reason why Sintx dropped Zimmers name and IPO'd for significantly less than its market equivalents despite generating more revenue than Implex when Zimmer announced its partnership with it. Just like theres a major reason today why the company has next to no market cap (~4mil) despite the fact that Silicon Nitride is destined to replace all other biomaterials as the dominate material. Max Link, Ph.D. has served as the Chairman of our board of directors since October 2003. Dr. Link served as Chairman of the Board and Chief Executive Officer of Centerpulse AG, the largest orthopedics company in Europe, from March 2002 until October 2003, when Centerpulse was acquired by Zimmer Holdings, Inc. Prior to joining Centerpulse, Max E. Link, Ph.D. has served as the chairman of our board of directors since October 2003. Dr. Link was chairman of the board of directors and Chief Executive Officer of Centerpulse AG, a medical implant company from March 2002 to October 2003. Prior to joining Centerpulse, Aaron A. Hofmann, M.D. is our co-founder and has been a member of our board of directors since 1996. Dr. Hofmann is a nationally and internationally recognized orthopedic surgeon, known for his accomplishments in developing total hip and knee replacement systems, innovative surgical approaches in hip and knee surgery and basic research on human bone dynamics. Dr. Hofmann holds 14 patents, many of which are directed at inventions involving hip and knee implants. Since 2003, Dr. Hofmann has been a design surgeon for Zimmer Holdings, Inc., the largest orthopedics company in the world. Dr. Hofmann, working with a team of orthopedic surgeons, helped design Zimmer’s new gender knee specifically designed for women.
Joe is right, theres a reason SINT trades the way it does just like theres a reason why this information was removed/not included when the company went public. What is it?
Dr. Max Link, PHD (Chairman 2003-2014)
Next if you look at the summary of Dr Aaron Hofmann, cofounder of Sintx and a member of the board of Sintx when Sintx first tried to IPO, you'll see inclusion of him being a surgeon designer for Zimmer in the 2007 IPO paperwork. Yet the information about Dr Sonny Bal, also a board member, the fact that hes a surgeon designer for Zimmer in the 2013 IPO paperwork is not disclosed.
Dr. Hofmann, MD
B. Sonny Bal, M.D. has served on our board of directors since February 2012. Dr. Bal is Professor & Chief of Adult Reconstruction at the University of Missouri, Columbia, specializing in hip and knee replacement surgery. He also is an Adjunct Professor of Material Sciences at the University of Missouri at Rolla. Dr. Bal is a member of the American Academy of Orthopaedic Surgeons and the American Association of Hip and Knee Surgeons. Dr. Bal received his M.D. degree from Cornell University and an M.B.A. from Northwestern University, and a J.D. from the University of Missouri. Dr. Bal is a licensed attorney and co-founder of the Bal Brenner law firm in North Carolina.
We believe that Dr. Bal’s expertise in orthopedic surgery and his specialty in hip and knee replacement surgery qualifies him to serve on our board of directors.
Designer Surgeon Panel, Zimmer Inc., Warsaw, Indiana, 2002 to present.
Total Joint Reconstruction Clinical Advisory Panel, Amedica Inc., Salt Lake City, UT, 2005 to present.
AnonymousMay 24, 2011 at 3:42 PM
Zimmer is looking at purchasing Amedica flat out for their techology to bolster sales in spine through licensing and to purchase the next generation of hip and knee implants. You heard it here on TSB.
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
From the ST board (seems pretty accurate):
10000 invested In TSLA at ipo is worth 1.5 mil. 10000 ivestwd in this scammy penny stock at it’s ipo is worth about 1 penny
Morgan Ceramics & NP Aerospace spin-off SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT; “SINTX” or the “Company”), a manufacturer and developer of advanced ceramic materials and related technologies, announced today that it has entered into a 10-year, Long-Term Agreement (LTA) with a leading manufacturer of aerospace components and systems. Under the LTA, SINTX will manufacture and supply key ceramic aircraft engine components which have been qualified through a rigorous evaluation process.
2016 (earlier?), Sintx began a Ceramic-Metal Brazing project in a joint effort with later disclosed Morgan Advanced Ceramics. Sintx would use the tech for spine/knee and Morgan would use the tech created for aerospace applications. Incidentally, the February 21st, 2024 PR disclosure announcing the supply of aerospace components could be a deal to supply Morgan Technical Ceramics. If Morgan is not the "world leader in aerospace systems" mentioned in this PR, then i'd expect another announcement of such a supply deal to Morgan Ceramics. More than likely this supply deal is to Morgan Ceramics which is curiously not disclosed despite the previously disclosed collaboration with Morgan Ceramics back in 2017.
“We are excited to serve our customer who is a world leader in aerospace systems,” said Dave O’Brien, Executive Vice President and Chief Operating Officer for SINTX.
A metal-ceramic brazing project with a global ceramics manufacturer is underway, targeting the total knee market, and composite devices in the spine market.
Enter a JDA with Morgan Ceramics
Current partnerships
Morgan Advanced Ceramics
Develop a spine device utilizing Morgan's advanced joining technologies
Developing spine & knee implant with Morgan Ceramics. This would braze Si3N4 & unknown metal together, something Morgan specializes in. Morgan is also attempting to utilize this same technique for aerospace market. If successful Morgan would commercialize and sell to entities like NASA. No signed JDA we are aware of.
After months of financial, legal and company due diligence, we finalized the deal towards midnight on November 20th
SINTX Technologies, Inc. (NASDAQ: SINT) announced today that it has hired Donald J. Bray as Vice President of Business Development. Mr. Bray was formerly Vice President of Technology at Morgan Advanced Materials, where he focused on leading strategic initiatives into new market areas. Mr. Bray will assume the new role at SINTX on 22 April 2019.
Business Director, Armor Jan 2008 - Sep 2014 6 yrs 9 mos
NP Aerospace, the world’s most advanced, composite armor company, has incorporated in the United States to provide advanced, composite tactical and combat-armored systems for vehicles and personal protection systems specifically for the U.S. military.
Did you major in finger painting or something? The fact that someone regurgitating entry level business concepts is some revelation to you explains why you can’t understand why this company/stock is where it is today.
Gotta hand it to Sonny. Even the fake bulls on the other board haven't made anything (yet). Lol, what a piece of work!! Another new record low today. That's a good thing!
Previously i wondered about why Zimmer Biomet stopped innovating Spine in-house and postulated that this was because it was eyeing innovation externally. This was based on a comment from ZimVie CEO and the fact that ZimVie announced it was dumping its Spine business to a hedge fund like the products are obsolete. This deal closed April 1st. So I think, the underlying concern that we had with our portfolio was we haven't innovated since the acquisition of LDR, and we needed to continue to innovate the portfolio specifically to Mobi-C. So there's a couple of things we're doing there. ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced it has entered into a definitive agreement to sell its spine business to H.I.G. Capital, a leading global alternative investment firm. In Figure 1, you can see J&J makes most of its money from pharmaceuticals and medical devices. They have grown these two sectors over the past decade through major capital investments in acquisitions and people development. Instead of investing in developing technology in-house, they use their size to acquire smaller companies who they believe have a promising trajectory in the healthcare space.
Previously I stumbled onto this quote pertaining to how J&J does exactly that, eye innovation externally and acquiring it rather than investing inhouse.
Dr. Bal confirmed during a 2021 conference call this very thing when he said that big companies look to small companies to develop/derisk that IP and then acquire it.
These are risk-averse companies that look to smaller companies like us to develop an idea, uh, and, uh, de-risk it, so to speak, and then buy that technology.
Look at that, 911 and UFOs are brought up. Ok, i'll rise to the occasion and post about those subjects. Yes, i tackle all sorts of subjects and often go against the main narrative being propagated just like i do here.
Zimmer Biomet, more likely a subsidiary like Biomet was Sintx strategic partner in regards to developing a hip implant utilizing Sintx femoral head.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174227775
Tesla = Fake it until it makes it scam. Making it one of the biggest scams in the world
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174140963
Climate Change is not actually caused by human activity, at most we play a tiny role. The real cause is earths weakening magnetic field which allows greater levels of radiation into the atmosphere and to the surface. Warming will become cooling as more heat is lost into space. This is why the upper atmosphere is cooling. In time that coldness will work to the lower atmosphere (think its already started). Winter is coming.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172052469
In regards to 911, when you understand how badly people within the US government wanted to leave the 1972 Anti-Ballistic Treaty, the fact that 911 was used justification to leave the treaty, you are faced with two possibilities. Either elements within the US government got extremely lucky that terrorists saved the day for them as the US was months away from violating said treaty, or it orchestrated it itself to create the justification so it could leave the treaty. I cover this in these two posts:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174053594
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172807753
UFOs, or really flying saucers, are in fact manmade, not extraterrestrial. The core tech was invented by Viktor Schauberger back in the late 1930s before the Nazis seized him and his designs. Nazis further developed the tech and after WWII was over that tech was brought to the US along with Mr. Schauberger. This explains why flying saucers were first seen after the end of WWII.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172786340
========================================
A basic roadmap laid out of Zimmer's intentions for Sintx back in 2011. This quote predates Sintx vast IP portfolio expansion. Any markets Zimmer Biomet does not currently participate in, that Sintx does, represents potential markets Zimmer Biomet can utilize Sintx to bolster its revenue through licensing as well as diversify those revenue sources.
AnonymousMay 24, 2011 at 3:42 PM
Zimmer is looking at purchasing Amedica flat out for their techology to bolster sales in spine through licensing and to purchase the next generation of hip and knee implants. You heard it here on TSB.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics
Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'.
One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Yes, they had the COVID Mask => Complete failure.
The goal of this agreement is to develop a safe and effective consumer face mask with broad-spectrum antibacterial and antiviral activity, based on incorporating SINTX’s unique silicon nitride powder into the mask filter and fabric. The successful development of such a product may help prevent the spread of respiratory diseases by catching and inactivating SARS-CoV-2 and other viruses and bacteria in the mask itself before they can enter into the human body.
We have several partnerships exploring opportunities in face masks, filters, wound care, and coatings.
Armor => Up in Smoke
The Company will be replacing the damaged furnace and expects the repaired furnace to be up and running in the 4th quarter 2024. Company management continues to work with third parties to temporarily outsource the sintering process.
1. Consistent Negativity: One of the key indicators of a stock basher is their consistent negativity towards a specific stock or company. They tend to focus solely on the negative aspects, exaggerating any potential issues or challenges while ignoring positive developments. For example, if you come across an individual who consistently posts negative comments about a company's financials without acknowledging any positive growth or potential opportunities, it could be a red flag.
Some common red flags include exaggerated claims without credible evidence, anonymous sources providing negative information, or repetitive use of derogatory language towards a company or its management. By recognizing these warning signs, investors can make more informed decisions and avoid being swayed by false narratives.
AnonymousMay 24, 2011 at 3:42 PM
Zimmer is looking at purchasing Amedica flat out for their techology to bolster sales in spine through licensing and to purchase the next generation of hip and knee implants. You heard it here on TSB.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics
Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'.
One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant
You are! How could you forget 9/11 and ufo's? Anyway, I got this feeling that nasdaq may actually be hitting the tolerance bar with this one. We'll see. Don't forget the 100 shares. Ya never know the goodies that are in store for you....
On a side note, I checked out some of the Pharma board today. Pretty interesting the comments as to whom is involved with Sint (but not Zimmer) lol. I had no idea Bal apparently testified a few times against them. If true that can only mean one thing in bizarro world: ties are tighter than ever between the two!
You do realize you are debating someone who makes DaVinci look like the antithesis of a renaissance man right?
Subject matter expert on the following: corporate finance, accounting, biochemistry, mechanical engineering, orthopedics, arthroplasty, market technician, law, mergers and acquisitions, neuroscience, automotive engineering, avionics, and I’m sure I’m missing a few.
According to this the expense would be recorded in the same period as payment if the upfront payment pertained to any of the following:
If the payment to Research Corp represented an advance payment for specific materials, equipment, or facilities with no alternative future use, the payment would be recognized as R&D expense in the period of payment.
Yes, they had the COVID Mask => Complete failure.
Armor => Up in Smoke
AnonymousMay 24, 2011 at 3:42 PM
Zimmer is looking at purchasing Amedica flat out for their techology to bolster sales in spine through licensing and to purchase the next generation of hip and knee implants. You heard it here on TSB.
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
As I've mentioned before, you are correct. His latest is the usual cop out of ignoring or dismissing, while he rehashes stuff that has zero to do with the company's present and probably future state. Hopefully, nasdaq puts an end to this miserable charade of a 'public' company and CEO, and people like myself, won't even be tempted anymore to deal with the (his) nonsense. Eight years is certainly enough. Thanks again for the reminder.
As for Sintx itself, why did it go public in the first place? Answer: to raise funds and awareness that they wouldn't have been able to, remaining as a private entity. And now they continue 'public' (with the rotten reputation they have deservedly acquired) or go back to being private? Neither will work, unless it was a scam all along, designed to enrich Zimmer, Sonny and whomever else, that was in on the scheme.
Guys - This idiot relishes the argument ad nauseum, facts/truth be damned.
Why do you indulge him?
Ive always known that the 2.5m payment paid Q2 2017 is the same 2.5m that was loaned to Sintx Q3 2017 via Sonnys investment fund. However i continue to screw up the details.
For a long time i treated it like it was milestone payment, but Certain R&D payments are upfront payments for IP. My last post i said the payment was to acquire IP already developed. However usually upfront payments are for access to IP to be developed.
Certain R&D agreements relate to agreements with upfront payments to obtain intellectual property to be used in R&D projects
I have a materials science research program at the Missouri Science & Technology University in Rolla, MO. My colleague, Prof. Rahaman and I have worked with bioactive ceramic technology, training and preparing many graduate PhD students from around the world. With our colleagues from Kyoto, Japan, we are developing super-tough silicon nitride ceramics for hip and knee replacement. Research, grants, publications, and patent filings are listed in my curriculum vitae, located here
Dr. Bal receives royalties from Zimmer, Inc.
that have no alternative future use in other projects.
Company A cannot use the technology for any other project or otherwise assign or transfer the technology. Company A has not yet concluded if economic benefits are likely to flow from the compound or if relevant regulatory approval will be granted.
The agreement stipulates that Company A will be permitted to use Company B’s technology in its own facilities for a period of three years. Company A will make a non-refundable payment of $3 million to Company B for access to the technology.
Company A should expense the $3 million when incurred (normally when paid) as research and development costs since the technology has no alternative future uses.
Company A pays the CRO a non-refundable, upfront payment of $3 million in order to carry out the research under the agreement. The CRO will have to present a quarterly report to Company A with the results of its research. Company A has full rights to the research performed,
AnonymousMay 24, 2011 at 3:42 PM
Zimmer is looking at purchasing Amedica flat out for their techology to bolster sales in spine through licensing and to purchase the next generation of hip and knee implants. You heard it here on TSB.
Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'.
One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant
See how he continues to lie and deflect?
His comment: Joe and Madg ignore 'that information' in their posts focus instead on something we already knew was coming. Anything to distract i guess.
My comment earlier regarding that information: I am assuming Boston is 100% correct in his EVERY assumption, assertion, and proof of company's products, connections with other companies, along with shared interests and stakeholdings of said companies...
By giving him a 100% acknowledgment to his assertions etc, I cut to the chase as to WHY (the opposite of distracting) the company trades like crap....something he cannot accept or even address because you see folks, Boston cannot admit he's ever wrong....and so the ONLY possible reason could be nefarious actions by everyone EXCEPT a lousy CEO and a mindset which cannot accept THAT simple TRUTH! This is why he always twists and turns.
He claims masks aren't a failure because bigger and better than O2 are in the works; Sonny's strengthening Sint etc. But like his mentor, these words (similar to Sonny's great business announcements) never seem to actually materialize. Hmm. Meanwhile, Sint is on the verge of delisting once again; the stock's had a massive drop of over 99% in the last 2 years (something he has mentioned often as part of his "conspiracy" belief), which follows over a 99% drop previously; something he fails to EVER mention in his latest conspiratorial revelations.
These things, as we all know, only happen to 'misunderstood', 'everybody is against' companies, but NEVER could be the result of inept or corrupt management. Nope! To admit to that possibility would be to admit he was wrong in his assessments regarding management and is just like the rest us regular human beings in being fallible at times. Nope, can't ever do that. After all, as a man thinks, so he is....and this individual thinks he has an understanding above anything that would dare to contradict, with a special commission to boot. I've stated in other posts what appears to be clearly this individual's problem. But, I digress.....
Time to ante up again, Boston. You don't want to disappoint your mentor. I'd also suggest preparing yourself to find out the REAL reason if and why Sint gets delisted. We peons have a right to know.
Reverse split almost guaranteed to happen so hfunds that bought the recent offerings can increase their profits naked shorting/shorting post RS into the next round of offerings. The news about Nasdaq hearing was expected due to the below .10 threshold. Such easy profits for the funds buying the offerings coupled with being able to write off the loss on their offering shares.
Joe is correct in a previous post. Gotta buy some more shares post RS if share count drops below desired minimum in hopes to participate in future rights offerings. Rights offerings are the only way shareholders can protect themselves from the excessive shorting and naked shorting occurring here. Im hoping Sonny will allow holders of previous rights/preferred shares to exchange those rights for new ones if there will be another rights offering.
========================================
Evidence showing Zimmer Biomet, or subsidiaries, was Sintx strategic partner for the development of Sintx femoral head for hip implants.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174227775
========================================
I post that Zimmer Biomet was in fact a strategic partner in regards to Sintx femoral head and true to form, Joe and Madg ignore that information in their posts focus instead on something we already knew was coming. Anything to distract i guess. Like the comment about Mask. Bashers treat mask IP as if it was a failure but it was mostly a success as the IP was developed and is free to commercialize with a much larger company than O2. Like maybe Sintx will supply 3M's medical spin off company (Solventum) where Zimmer Biomets former CEO Hanson landed for some licensing revenue for Zimmer Biomet? That spin off just completed along with ZimVies discount sale of its spinal assets.
Post style reflect both that of disinformation and bashing techniques.
https://www.ethosdebate.com/lies-rhetoric-4-18-rules-disinformation/
1. Consistent Negativity: One of the key indicators of a stock basher is their consistent negativity towards a specific stock or company. They tend to focus solely on the negative aspects, exaggerating any potential issues or challenges while ignoring positive developments. For example, if you come across an individual who consistently posts negative comments about a company's financials without acknowledging any positive growth or potential opportunities, it could be a red flag.
3. Frequent Use of Emotional Appeals: Manipulative stock bashers often resort to emotional appeals in an attempt to influence investor sentiment. They may use fear tactics by highlighting worst-case scenarios or playing on investors' anxieties about losing money. By evoking strong emotions, they aim to create panic and prompt hasty selling decisions. It is crucial for investors to remain rational and evaluate information objectively rather than succumbing to emotional manipulation.
4. Impact on Companies: Stock bashing not only affects investors but also has real consequences for the companies being targeted. Persistent negative sentiment can damage a company's reputation, making it harder for them to attract investment capital or secure partnerships. Moreover, if stock bashers succeed in driving down the stock price, it may become more challenging for the company to raise funds through equity offerings, potentially hindering their growth prospects.
Don’t worry, Boston will be sure to decipher the grammar within the sentences of the filing and the precise placements of commas to insinuate a buyout. I only say this because there is precedent
Gotta love how the company "plans to timely request a hearing" and here we are Apr 12 already (after receiving notice on Apr 8). So I'm assuming they're considering Apr 15, the last day they're allowed to, as being "timely". Knowing Sonny, how could I think anything other? What's interesting, that I didn't notice before, is that this is NOT the 30 day bit of being under a buck, but rather the possibility of being delisted because they've been a dime or less for 10 days. Let's see if poor ol' Sonny and Sint can dodge yet another bullet. Their shareholders have certainly taken quite a few.
What Sonny gets paid for.....
Filing extensions haha
On April 8, 2024, the Company received a new notification letter from the Staff notifying the Company that, as of April 5, 2024, the Company’s common stock had a closing bid price of $0.10 or less for ten consecutive trading days and that, consistent with Nasdaq Listing Rule 5810(c)(3)(A)(iii), the Staff has determined to delist the Company’s common stock from The Nasdaq Capital Market. The notice further provides that the Company has until April 15, 2024, to request a hearing before an independent Hearings Panel (the “Panel”).
The Company plans to timely request a hearing before the Panel, which request will automatically stay any suspension or delisting action at least pending the completion of the hearings process and the expiration of any additional extension period that may be granted by the Panel following the hearing. In accordance with the Nasdaq Listing Rules, the Panel has the authority to grant the Company an extension through October 7, 2024; notwithstanding, there can be no assurance that an extension will be granted or that the Company will ultimately regain compliance with all applicable requirements for continued listing on The Nasdaq Capital Market.
The following will show that Sintx had, at the time of data release in 2017, a strategic partnership with Zimmer Biomet (likely a subsidiary like Biomet) pertaining to development of a hip implant using only Sintx femoral head component. It however did not have a strategic partnership to develop products using its coating technology for hip and knee products.
I suspect that the 2.5m dollar payment Zimmer Biomet made Q2 2017 was done to acquire the implant prototype that was created using Sintx femoral head and Biomets liner as Zimmer Biomet would not intend to release a hip implant using Sintx femoral head only. Id bet it would want to keep this prototype for in-house testing purposes. This still begs to question who received the 2.5m for this prototype? That entity, likely an entity connected to one of the Universities involved (University of Missouri?), then used Dr Bals investment firm to loan to Sintx July 2017.
2015 10K
We are incorporating our silicon nitride technology into silicon nitride-coated metal components and solid silicon nitride components for use in total hip and knee replacement product candidates that we plan to develop in collaboration with a strategic partner.
This femoral head is expected to articulate against a cross-linked polyethylene liner fixed into a metal acetabular cup. Together with a strategic partner, we have initiated biomechanical testing of our solid silicon nitride femoral heads. This testing is expected to continue through 2016
although we have not yet entered into an agreement with any strategic partner to develop products with these silicon nitride-coated components
Together with a strategic partner, we have initiated biomechanical testing of our solid silicon nitride femoral heads. The results of this test will be released in 2017
Amedica and Zimmer-Biomet (Tokyo Office) provided the femoral heads and acetabular liners; however, neither company actively sponsored the research.
As we continue to gather evidence that silicon nitride femoral heads are superior in terms of wear performance, taper corrosion, strength and in vitro hydrothermal stability, we eventually intend to commercialize this product in cooperation with a strategic partner.
A basic roadmap laid out of Zimmer's intentions for Sintx back in 2011. What follows is a list of actions taken by Zimmer, Biomet, Sintx that are consistent with what this quote lays out as well as confirmation that Silicon Nitride is one of the new generation of materials as indicated in this quote.
AnonymousMay 24, 2011 at 3:42 PM
Zimmer is looking at purchasing Amedica flat out for their techology to bolster sales in spine through licensing and to purchase the next generation of hip and knee implants. You heard it here on TSB.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Let the line out $$$$$ get ready to set the hook and start reeling $$$$$
Expect the usual. Notice how real counterpoints are never addressed and many times not even acknowledged...just that Sint is victimized and there's only ONE who recognizes it. I guess it's kinda easy when the only individual you really listen to is....yourself. Meanwhile, looks like someone is gonna have to ante up again to make the 100 share 'voting rights' quota....
Let's see what perfect Sonny has to say on the 14th...or is that 15th? I'm so confused lol.....
“You madg were once a bull who had my confidence and then you switched sides where youve remained ever since”
You mean when they announced weigao? I started posting when there was the fda anticipation buildup in 2015. And when they had the toxic financing that I was warning everyone about but no one listened? Weigao made me think they had something, the longer it drew out with no updates I knew something was wrong. Sonny had me again with the masks and covid related possibilities but once again fumbled all of it. I don’t trust people who can’t adapt their perspective.
Once again you are accusing me of being some nefarious person when you know I’m not but you just like to pretend I am for your conspiracy. I recommended AMD to you at $4 and that you shouldn’t overload on this stock and that is only deemed kind of simcere? You’re a fckin moron
Sint...the ultimate victim according to the vast multitude of.....one. Let us not forget to attend the Special Meeting on Wednesday, May 14....
YES Sonny is creating value and theres a major problem with the market that instead of reflecting that value the stockprice has gone down. As i said previously the better position Sintx seems to be in the quicker the stockprice has dropped due to 50% haircuts the moment an offering has been announced and then another 50% haircut after the offering with no negative news to justify those drops outside the offerings (something the SEC needs to investigate). We are talking marketcap below cash and other assets as revenue began increasing.
Social media then spins out every negative thing to help justify the drops from the shorting and naked shorting. Markets are things persons can manipulate. So you have to look at what the business is doing to see if what the market is showing reflects what the business is doing.
You can see in the following image that instead of continued recovery as it should have starting in 2022 the stockprice deviated from the trend and began diving for no reason whatsoever other than those 50% haircuts ive already mentioned.
https://i.imgur.com/DFHiIUR.jpeg
========================================
Im putting together a list of everything that Sonny and Zimmer have done to confirm this quote but its really just a list of different parts from the connections between the companies.
A basic roadmap laid out of Zimmer's intentions for Sintx back in 2011. This quote predates Sintx vast IP portfolio expansion. Any markets Zimmer Biomet does not currently participate in, that Sintx does, represents potential markets Zimmer Biomet can utilize Sintx to bolster its revenue through licensing as well as diversify those revenue sources.
AnonymousMay 24, 2011 at 3:42 PM
Zimmer is looking at purchasing Amedica flat out for their techology to bolster sales in spine through licensing and to purchase the next generation of hip and knee implants. You heard it here on TSB.
Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'.
One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant
NO!!!!!!!!! One thing I've stated continually in one way or another is THAT BIG $$$$$ does NOT follow ignoramuses running companies. I gave you 3 reasons off the top of my head in my last msg, why management runs this outfit in 'loser' fashion from an investor's pov. Sonny does just the OPPOSITE of what you declared here. He may be increasing value, but NOT for the investor. The BIG difference between you and everybody, is YOU don't recognize this and so you keep on harping on an issue which is NOT the central issue for an investor. No one wants to lose on an investment. Period! In that way banks, brokerages and big spenders are just like us. And so they stay and stayed away. With no evidence of change in Sintx' 'style' (for lack of a better word), eventually retail wises up as well (banks and brokerages always understood apparently...as have insiders, sans Sonny's one timer) and thus reverse splits, along with similar, must increase in order to keep $$$$ flowing in. Simple isn't it? I didn't think so....200 to 300 reverse coming next...
Trust me for once: there's no wtf going on with this investor. I've seen these types play out many times over the years along with the one or two retailers who never seem to quite get it. If there is the wtf moment for me, it's that retailer, not the company or larger investment community which causes it.
Thus everything Sonny is doing is increasing Sintx value
"To go on and on as to the possibilities and probabilities of Sint's products and/ connections (I am assuming Boston is 100% correct in his EVERY assumption, assertion, and proof of company's products, connections with other companies, along with shared interests and stakeholdings of said companies and yet it) is a COMPLETE WASTE AS LONG AS NOTHING CHANGES WITH THE COMPANY'S WAY OF DOING BUSINESS (if one can even call it 'business')."
I have always been sincere.
is the sole reason I stayed so that I can watch you get zeroed out on this.
AnonymousMay 24, 2011 at 3:42 PM
Zimmer is looking at purchasing Amedica flat out for their techology to bolster sales in spine through licensing and to purchase the next generation of hip and knee implants. You heard it here on TSB.
Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'.
One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant
This and your last post, well said.
Maybe paranoia is rubbing off on me and so I will make one last attempt to clarify something from my last post, lest my words are twisted yet again.
Let me reword something I said earlier...
"To go on and on as to the possibilities and probabilities of Sint's products and/ connections (I am assuming Boston is 100% correct in his EVERY assumption, assertion, and proof of company's products, connections with other companies, along with shared interests and stakeholdings of said companies and yet it) is a COMPLETE WASTE AS LONG AS NOTHING CHANGES WITH THE COMPANY'S WAY OF DOING BUSINESS (if one can even call it 'business')."
Now why this is brought up time and time again by him, I do not know except.....it's never been MY point of contention. I won't even consider going there (regardless how I'm prodded) UNTIL Sint changes management or management changes their ways (the latter will NOT happen) and so the argument is and remains moot to this poster.
I have always been sincere. You think I’m here to distract but everything I have said has stood to be true.
Like I said years ago, you continuously accusing me of things that I am not is the sole reason I stayed so that I can watch you get zeroed out on this.
So you can pretend that you had no vitriol towards me or not, but you slandering me and throwing false accusations at me based on nothing other than the fact that you didn’t like what I posted was simply to discredit everything I posted. Yes and that is after repeatedly telling you that everything you were saying about me is false and slander and you know better because you are well aware that I’m not.
Remember you found out the kind of money I bring down and you asked me to invest in your retirement home startup? Ya I certainly wasn’t fake then was I? lol such a joke
Every one of us has biases and that's a problem when it comes to objectivity. What we do in order to counter those innate or conditioned biases is a different story. The FACT that you can continue to defend the indefensible viz Bal and the company's contempt and disregard for their constituents is incomprehensible UNLESS you suffer from some sort of condition (which I firmly believe you do) OR you're in cahoots with the company's leadership. There is absolutely NO excuse for leadership to continue as they have been. NONE! For one, such as yourself to continue to be in denial or whatever, shows there is a problem on your end. I've already stated what I believe your issues are. To go on and on as to the possibilities and probabilities of Sint's products and/ connections is a COMPLETE WASTE AS LONG AS NOTHING CHANGES WITH THE COMPANY'S WAY OF DOING BUSINESS (if one can even call it 'business'). I WAS here when the joke with O2 blew up. I WAS here when Bal announced they were good with finances and didn't need to go to the well. And I'm here AGAIN when the dopes can't even correctly put out a recent filing with the right date and day. Like I said in 2016 concerning Ashton and his ilk, there's a reason these jokers pick THESE types of companies.
My agenda has always been clear, and that is a public company has a responsibility towards its shareholders. I haven't deviated from that central theme since I've been on Ihub (Including my time on the Sint forum). Like madg and others, you have continued throughout to accuse me of being part of the problem, whether by using various aliases, disinfo tactics, a conspiracy-driven agenda to bring the company down....whatever...doesn't matter. The FACT that you ALONE now defend this company and its ways, especially management's, shows everyone all they need to know (you have a serious problem or you're a company plant). There's really nothing left to say to you. However, I WILL on occasion as I see fit, explain to those who may be new, that this isn't and has never been a sound investment (regardless of products, connections between companies etc), based solely on the antics of leadership. Enjoy your life.....
Theres no doubt i walked right into that with my sincerity, but what does that say about you and your agenda that you resorted to exploiting it? Again you're attacking the messenger instead of the message. Have to convey the messenger is crazy since you cant dispute the facts contained within that message? Regardless, that doesnt change the fact that what the author of that post said continues to be true and has been validated by both Zimmer Biomets and Sintx actions.
Since society is made of narrative and power ultimately rests in the hands of those who are able to control those narratives, it makes no sense to fixate on individuals and it makes perfect sense to focus on narrative. What narratives are being pushed by those in power? How are those narratives being disrupted, undermined and debunked by things that are being said by dissident voices? This is the most effective lens through which to view the battle against the unelected power establishment which is crushing us all to death, not some childish fixation on who should or shouldn’t be our hero.
AnonymousMay 24, 2011 at 3:42 PM
Zimmer is looking at purchasing Amedica flat out for their techology to bolster sales in spine through licensing and to purchase the next generation of hip and knee implants. You heard it here on TSB.
AnonymousMay 24, 2011 at 3:42 PM
Zimmer is looking at purchasing Amedica flat out for their techology to bolster sales in spine through licensing and to purchase the next generation of hip and knee implants. You heard it here on TSB.
Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'.
One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant
Followers
|
240
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
41270
|
Created
|
02/13/14
|
Type
|
Free
|
Moderators Atlanta1 Tesla thru the roof |
https://www.youtube.com/watch?v=j94SgeyCh3M
(AMDA) Amedica Corp. - NASDAQ
RECENT NEWS
https://www.youtube.com/watch?v=hxbj7Sq7W94
https://www.youtube.com/watch?v=j94SgeyCh3M
https://www.youtube.com/watch?v=KbU47COpXx8
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |